Minovia Therapeutics Is A Clinical Stage Biotechnology Company Located In Tirat Carmelisraelthe Company Specializes In Developing Innovative Mitochondrial Cell Therapies Aimed At Treating Diseases Linked To Mitochondrial Dysfunctionincluding Both Genetic And Age Related Conditionsminovia Collaborates With Scientistscliniciansand Patient Advocacy Groups To Enhance Its Therapeutic Offerings The Company Utilizes Its Proprietary Mitochondrial Augmentation Technologymatplatformwhich Enriches Hematopoietic Stem Cells With Healthy Mitochondria To Restore Their Functionminovia S Lead Product Candidatemnv 201Is Designed To Treat Patients With Mitochondrial Diseases Caused By Mtdna Mutations Or Deletionscurrentlymnv 201 Is Undergoing Clinical Studies For Pediatric Patients With Conditions Such As Pearson Syndrome And Kearns Sayre Syndromeas Well As For Low Risk Myelodysplastic Syndrome Under The Leadership Of Co Founder And Ceo Natalie Yivgi Ohanaminovia Aims To Be A Leader In Mitochondrial Cell Therapiessupported By A Team Of Experts Dedicated To Addressing Unmet Clinical Needs In This Field
No conferences found for this company.
| Company Name | Minovia Therapeutics Ltd |
| Country |
Israel
|
| Address | N/A |
| Telephone | N/A |
| N/A |
